Vetoquinol: 2024 Calendar of Financial Communication
04 1월 2024 - 2:00AM
Business Wire
Regulatory News:
Vetoquinol (Paris:VETO) published its calendar of financial
communication for 2024.
- January 24, 2024: 2023 Annual revenues (after market)
- March 20, 2024: 2023 Annual results (confcall after
market)
- April 29, 2024: 2024 First quarter revenues (after market)
- May 28, 2024: Annual shareholders’ meeting
- June 6, 2024: Dividend payment
- September 12, 2024: 2024 First semester results (confcall after
market)
- October 30, 2024: 2024 Third quarter revenues (after
market)
Next update: Annual Sales 2023, January 24th, 2024 after
market close
ABOUT VETOQUINOL
Vetoquinol is a leading global animal health company that
supplies drugs and non-medicinal products for the farm animals
(cattle and pigs) and pet (dogs and cats) markets. As an
independent pure player, Vetoquinol designs, develops and sells
veterinary drugs and non-medicinal products in Europe, the Americas
and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has pursued a strategy combining innovation with
geographical diversification. The Group’s hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. Vetoquinol employed
2,497 people as of June 30th, 2023.
Vetoquinol has been listed on Euronext Paris since 2006 (symbol:
VETO).
The Vetoquinol share is eligible for the French PEA and PEA-PME
personal equity plans.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103910180/en/
VETOQUINOL
Investor Relations Fanny Toillon Tel.: +33 (0)3 84
62 59 88 relations.investisseurs@vetoquinol.com
KEIMA COMMUNICATION
Investor & Media Relations Emmanuel Dovergne
Tel.: +33 (0)1 56 43 44 63 emmanuel.dovergne@keima.fr
Vetoquinol (EU:VETO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Vetoquinol (EU:VETO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024